Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Solasia Pharma KK

4597
Current price
44 JPY -1.01 JPY (-2.22%)
Last closed 45 JPY
ISIN JP3436500007
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Tokyo Stock Exchange
Capitalization 10 156 265 441 JPY
Yield for 12 month +10.00 %
1Y
3Y
5Y
10Y
15Y
4597
21.11.2021 - 28.11.2021

Solasia Pharma K.K. engages in the development and marketing of oncology drugs in Japan and other Asian countries. The company offers episil oral liquid for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and radiotherapy for cancer; Sancuso, a transdermal delivery system that delivers granisetron, an anti-emetic into the patient's bloodstream for the treatment of chemotherapy induced nausea and vomiting; and Darvias injection, and antineoplastic agent/organic arsenic product indicated for relapsed or refractory peripheral T-cell lymphoma. It is also involved in the development of SP-04, a chemotherapy induced peripheral neuropathy which is in pre-clinical stage. The company was founded in 2006 and is based in Tokyo, Japan. Address: Sumitomo Fudosan Shiba-Koen Tower, Tokyo, Japan, 105-0011

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8 423.87 JPY

P/E ratio

Dividend Yield

Current Year

+625 939 813 JPY

Last Year

+1 107 822 174 JPY

Current Quarter

+60 869 289 JPY

Last Quarter

+11 159 437 JPY

Current Year

-165 361 718 JPY

Last Year

+671 591 857 JPY

Current Quarter

-32 463 704 JPY

Last Quarter

-94 347 444 JPY

Key Figures 4597

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -925 214 153 JPY
Operating Margin TTM -505 %
PE Ratio
Return On Assets TTM -32.32 %
PEG Ratio
Return On Equity TTM -61.27 %
Wall Street Target Price 8 423.87 JPY
Revenue TTM 162 318 275 JPY
Book Value 10.01 JPY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -80.6 %
Dividend Yield
Gross Profit TTM 671 591 863 JPY
Earnings per share -7.47 JPY
Diluted Eps TTM -7.47 JPY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics 4597

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 4597

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 4597

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 55.5973
Price Sales TTM 62.5701
Enterprise Value EBITDA -3.761
Price Book MRQ 4.984

Financials 4597

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 4597

For 52 weeks

23.33 JPY 72.03 JPY
50 Day MA 45.35 JPY
Shares Short Prior Month
200 Day MA 38.46 JPY
Short Ratio
Shares Short
Short Percent